| Position paper: epidemiology of periodontal diseases. B Burt Journal of periodontology 76 (8), 1406-1419, 2005 | 808 | 2005 |
| Bivalirudin started during emergency transport for primary PCI PG Steg, A Van't Hof, CW Hamm, P Clemmensen, F Lapostolle, P Coste, ... New England Journal of Medicine 369 (23), 2207-2217, 2013 | 559 | 2013 |
| Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance SA McKee, DC Sane, EN Deliargyris Thrombosis and haemostasis 88 (11), 711-715, 2002 | 268 | 2002 |
| Role of nuclear factor‐kappa B (NF‐κB) in inflammation, periodontitis, and atherogenesis TC Nichols, TH Fischer, EN Deliargyris, AS Baldwin Jr Annals of Periodontology 6 (1), 20-29, 2001 | 148 | 2001 |
| Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction RJ Raymond, GJ Dehmer, TC Theoharides, EN Deliargyris American heart journal 141 (3), 435-438, 2001 | 145 | 2001 |
| Bivalirudin versus heparin anticoagulation in transcatheter aortic valve replacement: the randomized BRAVO-3 trial GD Dangas, T Lefèvre, C Kupatt, D Tchetche, U Schäfer, N Dumonteil, ... Journal of the American College of Cardiology 66 (25), 2860-2868, 2015 | 131 | 2015 |
| Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure EN Deliargyris, RJ Raymond, TC Theoharides, WS Boucher, DA Tate, ... The American journal of cardiology 86 (9), 913-918, 2000 | 129 | 2000 |
| Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary … U Zeymer, A van't Hof, J Adgey, L Nibbe, P Clemmensen, C Cavallini, ... European heart journal 35 (36), 2460-2467, 2014 | 119 | 2014 |
| Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes RT Williams, LV Damaraju, MA Mascelli, ES Barnathan, RM Califf, ... Circulation 107 (18), 2307-2312, 2003 | 110 | 2003 |
| Benefit and risks of aspirin in addition to ticagrelor in acute coronary syndromes: a post hoc analysis of the randomized GLOBAL LEADERS trial M Tomaniak, P Chichareon, Y Onuma, EN Deliargyris, K Takahashi, ... JAMA cardiology 4 (11), 1092-1101, 2019 | 96 | 2019 |
| Mast cell tryptase: a new biomarker in patients with stable coronary artery disease EN Deliargyris, B Upadhya, DC Sane, GJ Dehmer, J Pye, SC Smith Jr, ... Atherosclerosis 178 (2), 381-386, 2005 | 92 | 2005 |
| Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography) P Clemmensen, S Wiberg, A Van't Hof, EN Deliargyris, P Coste, ... JACC: Cardiovascular Interventions 8 (1 Part B), 214-220, 2015 | 90 | 2015 |
| Periodontal disease in patients with acute myocardial infarction: prevalence and contribution to elevated C-reactive protein levels EN Deliargyris, PN Madianos, W Kadoma, I Marron, SC Smith Jr, JD Beck, ... American Heart Journal 147 (6), 1005-1009, 2004 | 86 | 2004 |
| Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level … GW Stone, R Mehran, P Goldstein, B Witzenbichler, A van’t Hof, ... Journal of the American College of Cardiology 65 (1), 27-38, 2015 | 85 | 2015 |
| Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in … GW Stone, T Clayton, EN Deliargyris, J Prats, R Mehran, SJ Pocock Journal of the American College of Cardiology 63 (1), 15-20, 2014 | 84 | 2014 |
| Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges F Zannad, WG Stough, V Regnault, M Gheorghiade, E Deliargyris, ... International journal of cardiology 167 (5), 1772-1782, 2013 | 84 | 2013 |
| European workshop in periodontal health and cardiovascular disease consensus document P Bouchard, P Boutouyrie, F D'Aiuto, J Deanfield, E Deliargyris, ... European heart journal supplements 12 (suppl_B), B13-B22, 2010 | 68 | 2010 |
| Cardiotoxicity of cancer therapy KA Tolba, EN Deliargyris Cancer investigation 17 (6), 408-422, 1999 | 68 | 1999 |
| Characterization of the average daily ischemic and bleeding risk after primary PCI for STEMI G Giustino, R Mehran, GD Dangas, AJ Kirtane, B Redfors, P Généreux, ... Journal of the American College of Cardiology 70 (15), 1846-1857, 2017 | 64 | 2017 |
| Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention M Vaduganathan, RA Harrington, GW Stone, EN Deliargyris, PG Steg, ... Journal of the American College of Cardiology 69 (2), 176-185, 2017 | 53 | 2017 |
Jayne PratsELYSIS在 elysis-med.com 的电子邮件经过验证
